men, significant technical problems need to be solved first. 
Introduction through the use of growth factors, which have been shown to increase the transduction efficiencies of CML progenitors from Pluripotent hematopoietic stem cells (HSC) are a group of both BM 16 and peripheral blood 17 mononuclear cells. A risk highly specialized cells believed to be responsible for the lifeof the use of exogenous growth factors in this way is loss of long production of the formed elements of the blood. Chronic stem cell phenotype, specifically loss of repopulating myelogenous leukemia (CML), a hematologic malignancy capacity. originating within the pluripotent HSC compartment of the Incubation of cells and vector supernatant in direct contact bone marrow (BM), 1 is currently curable only by allogeneic with stromal cells has been shown to increase gene transfer bone marrow transplantation (BMT).
2,3 Patients ineligible for in primitive HPC. [18] [19] [20] [21] Application of this methodology for allogeneic transplantation can become candidates for autologclinical gene transfer would require the use of autologous ous BMT, however, disease relapse following autologous BMT stroma, which would be impractical and time-consuming to remains the major risk factor for the majority of these prepare for individual patients. As an alternative to stroma, patients.
4-6 For these reasons, alternatives or innovations to Moritz et al 22 have demonstrated that a BM extracellular BMT, such as gene therapy, are needed for treatment of the matrix molecule, the 30/35 kDa chymotryptic fragment of fibmajority of patients with CML.
ronectin (FN), greatly enhances RMGT into primitive and Evidence indicating the presence of normal HSC among committed BM HPC isolated from healthy individuals. In leukemic HSC in CML marrow [7] [8] [9] make this disease an attractaddition, these authors have demonstrated increased transive candidate for gene therapy protocols. CML cells can be duction of murine reconstituting HSC utilizing a recombinant identified by a unique mRNA transcript, BCR/ABL, repchimeric FN fragment expressed in E. coli, 23 which could easily be applied for clinical-grade RMGT protocols in lieu of autologous stroma.
Correspondence: CM Traycoff, PhD, Indiana University School of In these studies, the 30/35 kDa fragment of FN was used in Medicine 
. The LNL6 vector is amphotropically packaged in the PA317 cell line and described 27 on a FACStar plus (BDIS) flow cytometer. A primary gate containing cells of interest was established using forward has a titer of 2 × 10 6 colony-forming units/ml (CFU/ml). The G1Na and G1NaSvi2G.44 vectors were developed by Genetic Therapy (Gaithersburg, MD, USA), and are packaged in the of all patients are given in Table 1 . cultures were prestimulated with 200 ng/ml SCF, 100 ng/ml IL-3, and 50 ng/ml GM-CSF, while CD34 + HLA-DR − cultures cells). After two transductions 24 h apart, cells were extensively washed (three times), returned to the FN-or BSA-coated received 100 ng/ml IL-6 in addition to SCF, IL-3, and GM-CSF. The omission of IL-6 from CD34
+ HLA-DR + cell cultures was transduction plates, and assayed on days 3 and 8 post-transduction for IL-2 production by ELISA, and on day 8 post-transbased on our previous data 16 suggesting a detrimental effect of IL-6 on the transduction efficiency of CML progenitors. All duction by PCR for Neo R . cytokines were kind gifts from Amgen, Thousand Oaks, CA, USA.
Hematopoietic progenitor cell assays
Transduction protocol 2 ) or 2% BSA as predishes containing IMDM with 30% FBS, 5 × 10 −5 mol/l 2-merviously described. 22 Plates were either used immediately or captoethanol, 1.1% methylcellulose, 100 ng/ml SCF, 25 ng/ml stored overnight at 4°C. For experiments utilizing LNL6 and IL-3, 25 ng/ml GM-CSF, and 2 U/ml erythropoietin in a vol-G1N vector, 1 × 10 4 to 2 × 10 4 CD34 + HLA-DR + or CD34 + ume of 1 ml. Cultures of CML CD34 + HLA-DR − cells also HLA-DR − cells were incubated on plates with vector superreceived 25 ng/ml IL-6. The neomycin analogue, G418, was used at 1.0 mg/ml (active) in appropriate cultures. Cultures were incubated in 100% humidified 5% CO 2 in air at 37°C. After 14 days BFU-E, CFU-GM and CFU-GEMM were enumerated using an inverted microscope according to previously reported criteria. 28 Transduction efficiency was defined as
No. of G418-resistant colonies No. of cells plated in G418 ×
No. of cells plated without G418 × 100 No. of unselected colonies rtPCR detection of BCR/ABL Individual G418-resistant colonies were plucked into cold phosphate-buffered saline, washed, and processed for total cellular RNA isolation using Tri-pure isolation reagent. Cell pellets were resuspended in 1 ml Tri-pure isolation reagent containing 4.0 g MS2 bacteriophage RNA, lysed by repetitive pipetting, and incubated at room temperature for 5 min. Samples were mixed with 200 l chloroform, incubated for To synthesize cDNA, the RNA samples were pelleted, air-dried, and rehydrated in 40 l DEPC-treated H 2 O, followed ELISA for IL-2 detection by heating to 65°C (2 min) and quenching on ice. Ten microliters of the RNA samples were mixed with 5 l reverse tranExpression of the IL-2 gene vector in supernatant from transduced CML cells was assayed by the Human IL-2 DuoSet scriptase buffer, 0.5 mm dNTP solution (Perkin-Elmer (PE), Norwalk, CT, USA), 2.5 l hexanucleotide mixture, 30 units ELISA Development System (Genzyme, Cambridge, MA, USA) according to the manufacturer's directions. Briefly, 96-well RNase inhibitor, and 15 units AMV reverse transcriptase in a total volume of 25 l and incubated for 1 h at 42°C. The microtiter plates were coated overnight at 4°C with 100 l of monoclonal mouse anti-human IL-2 antibody (2.5 g/ml), and samples were incubated at 95°C for 5 min to denature the reverse transcriptase, and stored on ice until PCR amplifithen blocked with 250 l of PBS + 4% BSA. Wells were then incubated in sequence with: (1) 100 l of IL-2 standards or cation.
Two rounds of PCR using nested primers were performed supernatant from transduced cells, (2) 100 l of biotinylated polyclonal rabbit anti-human IL-2 (1.25 g/ml), (3) 100 l of with 10 l of cDNA mixed with 5 l PCR buffer (PE), 0.2 mm dNTP solution (PE), 0.2 g of each primer, 1.0 unit of Taq horseradish peroxidase-conjugated streptavidin diluted 1:1000 (20 min), (4) 100 l of 0.4 mg/ml o-phenylenediamine DNA polymerase (PE), and DEPC-treated H 2 O in a total volume of 50 l for 35 cycles on a PE9600 Thermal Cycler (PE) dihydrochloride + 0.4 mg/ml urea hydrogen peroxide (Sigma, St Louis, MO, USA) (20-30 min). Enzymatic reactions were (95°C for 90 s and 72°C for 120 s) followed by cooling to 4°C. Three microliters of the primary PCR product were subjected terminated with 25 l of 2N H 2 SO 4 , and absorbance read at 492 nm on a microtiter plate reader. Values of IL-2 standards to a second round of amplification using nested primers and identical parameters as above. Primers used were previously were used to construct a standard curve from which linear regression analysis was used to calculate supernatant IL-2 described by Keating et al. 29 First round primers (5′-AGCATGGCCTTCAGGGTGCACAGCCGCAACGGCAA-3′ (5′ concentrations. All incubations were preceded by three washes with PBS + 0.05% Tween 20, and were incubated at primer), and 5′-TCACTGGGTCCAGCGAGAAGGTTTTCCTT-GGAGTT-3′ (3′ primer)) amplify a 315 or 390 base pair 37°C for 1.5 h except where noted. sequence corresponding to the B2A2 and B3A2 BCR/ABL translocation, respectively. Nested primers spanned a 224 or 299 base pair sequence, 29 and are defined as: 5′-Results GTTCCTGATCTCCTCTGACTATGAGCGTGCA-3′ (5′ primer), and 5′-CTCAGACCCTGAGGCTCAAAGTCAGATGCT-3′ (3′ Effect of fibronectin on retroviral-mediated gene transfer of CML progenitors primer).
Amplification of ␤ 2 microglobulin (␤ 2 m) cDNA (335 bp) as RNA integrity control was performed as described above using Vector expression in purified CML progenitors, measured as G418 resistance, was compared in progenitor cell assays after 0.4 m ␤ 2 m primers (Clontech, Palo Alto, CA, USA): 5′-CTCGCGCTACTCTCTCTTTCTGG-3′ (5′ primer) and 5′-transduction of cells on either FN-or BSA-coated plates. Figure 3a shows that in four separate experiments, FN was GCTTACATGTCTCGATCCCACTTAA-3′ (3′ primer). Ten microliters of the nested BCR/ABL PCR product and ␤ 2 m proeffective in augmenting transduction of CML CD34 + HLA-DR − progenitors, yielding 11.0 ± 4.5% transduced progenitors duct were subjected to gel electrophoresis in 2% agarose and visualized by ethidium bromide incorporation. In each PCR compared to 3.3 ± 1.5% when BSA was used. FN was also effective in enhancing the transduction of CML CD34 + HLAanalysis, K562 RNA was included as a positive control, while negative controls included JY (a B lymphoblastic cell line) DR + cells (Figure 3b) , where a 17.3 ± 4.5% vs 3.7 ± 1.7% transduction rate was observed when FN was used in place RNA and the PCR reagents alone. A sample was reported to be BCR/ABL(−) only if that same sample proved to be ␤ 2 m(+) of BSA. Transduction efficiencies were increased in all types of progenitors (BFU-E, CFU-GM and CFU-GEMM) when the with appropriate positive and negative controls. + cells, respectively, by day 2 of culture (data not shown). In brief, 1.0-2.0 g of genomic DNA was resuspended in a total volume of 100 l and amplified by PCR for 35 cycles on a PE9600 Thermal Cycler (PE) (94°C for 60 s, 56°C for 60 s, and 72°C for 90 s). The reaction reagents were purchased in RMGT in normal BCR/ABL(−) CML progenitors kit form (GeneAmp) from Perkin Elmer Cetus. Primers amplify a 790 bp Neo R sequence contained in the IL-2 vector and are We have previously shown, by rtPCR analysis, that non-leukemic BCR/ABL(−) progenitors can be enriched from CML defined as: 5Ј-CAAGATGGATTGCACGCAGG-3′ (sense) and 5′-CCCGCTCAGAAGAACTCGTC-3′ (antisense). 30 Amplified marrow by isolating CD34 + HLA-DR − cells. 9 Since transduction of these cells have important clinical implications in the samples were subjected to ethanol precipitation and electrophoresed on a 3% NuSieve agarose/1% regular agarose gel.
treatment of CML, we investigated whether normal BCR/ABL(−)HPC were successfully transduced under our Southern blot analysis 31 was used to confirm the presence of the Neo R gene using a 32 P end-labeled 153 bp probe generexperimental conditions using FN. Individual progenitor cell colonies developing from CML CD34 + HLA-DR − cells transated by PCR with the following primers: 5′-AAAGTATCCAT-CATGGCTGAT-3′ (sense) and 5′-ATCTGGACGAAGAGCATduced on FN-coated plates were plucked from G418-containing cultures and analyzed by rtPCR for their BCR/ABL status. 3′ (antisense). actin, and other constitutively expressed genes, but the possibility of contaminating genomic DNA [32] [33] [34] [35] or pseudogenes, 35, 36 which, when amplified yield a PCR product similar detection of our ELISA, cells transduced over BSA-and FNcoated plates both produced demonstrable levels of Il-2 by day 3 following transduction. By day 8, the amount of IL-2 produced by cells transduced on BSA-coated plates was undetectable, while IL-2 production by cells transduced on FNcoated plates appeared to be sustained (Table 3) . PCR analysis for the Neo R gene demonstrated the presence of the transduced gene on day 8 in cells transduced over FN, but not in control cells or cells transduced over BSA (Figure 6 ).
Figure 5
Ethidium-bromide stained agarose gel of ␤ 2 m rtPCR products illustrating the absence of amplifiable ␤ 2 m pseudogenes. ␤ 2 m PCR was performed on cDNA reaction products in which reverse tran- In this report we illustrate a simple, effective means of increasing gene transfer in primitive CML leukemic and, perhaps more importantly, normal BCR/ABL(−) hematopoietic progeniin size to the predicted cDNA generated by rtPCR, have led tor cells. In these studies, RMGT of the Neo R gene carried out investigators to question the results obtained from these on plates previously coated with the 30/35 kDa chymotryptic experiments. We have tested for the presence of ␤ 2 m pseudofragment of FN increased the percentage of G418-resistant genes by performing PCR on cDNA reaction products in progenitors in five CML patient samples analyzed. These data which reverse transcriptase was omitted from the cDNA reacprovide a step towards the realization of clinically useful gene tion. As seen in Figure 5 , no template was amplified with the therapy protocols currently hindered by numerous technical ␤ 2 m primers under these conditions, indicating that ␤ 2 m difficulties, including low transduction efficiencies in primipseudogenes, if present, do not amplify with our selected pritive HPC. Using CML CD34 + and CD34 + HLA-DR + and CD34 The enhancing effect of stroma on retroviral vector supernatant is used, we transduced CML CD34
+ cells with the natant transduction in normal human BM and cord blood prohuman IL-2 gene vector at an MOI of 1:1.5. In these experigenitors has long been recognized. [18] [19] [20] [21] Stromal cells represent ments, FN was used at 20 g/cm 2 instead of 4 g/cm 2 as in only one component of the BM hematopoietic microenvironprevious experiments. As seen in Table 3 , while IL-2 proment, which consists of an organized network of multiple cell duction by untransduced control cells was below the level of types and extracellular matrix molecules involved in the adhesion and regulation of hematopoietic stem and progenitor patients relative to others (Figure 3 ), could be due to a larger percentage of normal BCR/ABL(−) HPC in these samples.
Control

Ͻ31.25 undetected
Although this point has not been directly addressed in this to have a beneficial effect on RMGT.
d Day 0, day 3 and day 8 represent the number of days following the second IL-2 transduction, which occurred on day 3 of the culture. suggesting that the enhanced gene transfer efficiency observed on FN may be due to a co-localization of retroviral vector and making amplification of genomic DNA unlikely. Finally, we tested for the presence of ␤ 2 m pseudogenes by performing target cells, not only an interaction between HPC and FN. In this regard, the adherence or lack thereof of CML progenitors rtPCR in the absence of reverse transcriptase, and showed that no PCR product was amplified ( Figure 5 ). To control against to FN may not be necessary to explain the observed enhanced transduction efficiency. It is tempting to speculate on the false positives or over-expression of ␤ 2 m, only one round of PCR was performed for ␤ 2 m, while two rounds of PCR were possibility of building the BM microenvironment with other extracellular matrix molecules in the hopes of further enhancperformed for BCR/ABL. For these reasons, it is likely that only samples in which intact RNA was isolated would give a posiing RMGT into primitive HPC and HSC with greater retention of the 'stem cell characteristics' of these cells.
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